The Economist

Felix  Oberholzer-Gee; Bharat N. Anand; Lizzie  Gomez

Case | HBS Case Collection | March 2010 (Revised July 2010)

The Economist

by Felix Oberholzer-Gee, Bharat N. Anand and Lizzie Gomez

Abstract

In 2009 the Economist continued to experience impressive growth and operating margins while many of its peers reeled from both a cyclical downturn and structural threats to print publishing. The case describes the history, organization, and business model of the Economist, and describes three issues confronting Andrew Rashbass, the group's chief executive: first, reevaluating the magazine's digital strategy; second, preparing for e-readers; and, third, positioning the company to exploit what the Economist described as an era of "Mass Intelligence" where more readers sought out sophisticated and challenging information sources.

Keywords: Business Model; Journals and Magazines; Growth and Development Strategy; Strategic Planning; Competitive Strategy; Online Technology; Publishing Industry; United Kingdom;

Format: Print

23 pages

Educators Purchase

Citation:

Oberholzer-Gee, Felix, Bharat N. Anand, and Lizzie Gomez. "The Economist." Harvard Business School Case 710-441, March 2010. (Revised July 2010.)

Case | HBS Case Collection | January 2018 (Revised May 2019)

Adeo Health Science: Turning a Product into a Brand

Elizabeth A. Keenan and Jill Avery

For decades, American parents were warned to avoid introducing potential allergens to their babies prior to their first birthday. But two influential clinical studies caused the medical establishment to radically reverse its position. Parents were now warned that delaying the introduction of these types of foods increased a baby's risk of food allergies. Adeo Health Science was ready, with patents filed for a baby food that made it simple for parents to introduce allergens. Now, the new company had to turn its product into a brand and map its go-to-market strategy, including creating a compelling value proposition, choosing a path to market that was either direct-to-consumer, through grocery retailers, or via the physician channel, and planning its marketing communications and sales strategy. As a new startup with constrained resources, the company knew its marketing decisions would make or break the new product.

Keywords: marketing; Startup; entrepreneurship; health care; consumer; consumer products; branding; brands and branding; marketing strategy; Marketing communications; Distribution; retailing; go to market strategy; Marketing; Marketing Channels; Marketing Communications; Brands and Branding; Marketing Strategy; Entrepreneurship; Health Care and Treatment; Consumer Products Industry; Health Industry; United States; North America;

Citation:

Keenan, Elizabeth A., and Jill Avery. "Adeo Health Science: Turning a Product into a Brand." Harvard Business School Case 518-065, January 2018. (Revised May 2019.) View Details

Cite View Details Educators Purchase

Zhejiang Geely Holding Company's acquisition of Volvo cars was widely viewed with skepticism because of the poor track record of cross-border auto industry acquisitions. This case looks at the acquisition and post-acquisition integration from the point of view of Chinese managers at Geely. A companion case, HBS No. 613-042, “Volvo Cars: Acquisition by Geely” looks at the acquisition from the point of view of Swedish managers at Volvo.

In 2000, Procter & Gamble Co. introduced Crest Whitestrips, a new, revolutionary product that allowed consumers to whiten their teeth at home. With Whitestrips, P&G created an entire new category in oral care, worth $460 million in 2002. Whitestrips sent P&G's main competitor in oral care, Colgate Palmolive Co., scrambling because several patents protected the strips, making it difficult for Colgate to copy the invention. But in September 2002, the tables turned. Colgate introduced Simply White, a favorably priced whitening product that consumers could simply paint on their teeth. One month after its introduction, Simply White had captured one half of the market, and Crest Whitestrips lost more than 50% of its share. However, P&G's tests of Simply White indicated that Colgate's new product was largely ineffective. Had Colgate just committed a major strategic blunder by introducing a product that did not work? And, if so, how could P&G best take advantage of the situation?

Faculty & Research

The Economist

Abstract

Citation:

About the Authors

More from these Authors